Shortcomings of Indian Chemical Industry: TIFAC

  • IASbaba
  • August 22, 2020
  • 0
UPSC Articles
Print Friendly, PDF & Email

Shortcomings of Indian Chemical Industry: TIFAC

Part of: GS-Prelims and GS-III – Industries

In News:

  • Recently, a report by the Technology Information Forecasting and Assessment Council (TIFAC) was released. 
  • TIFAC is an autonomous organisation and think-tank of the Department of Science and Technology. 
  • It has highlighted the shortcomings of the Indian chemical industry which prove to be barriers in competing with China.

Key takeaways 

  • India lacks enough technology, plants and infrastructure to manufacture key chemicals in a cost-effective and less polluting manner.
  • Manufacturing of several key Active Pharmaceutical Ingredients (API) are nearly stopped.
  • India depends on China for 67% of chemical intermediates and API and almost entirely for chloroquine and hydroxychloroquine (HCQ).
  • Manufacturers are unable to meet the price at which chemicals are produced by China.

Important value additions 

Active Pharmaceutical Ingredients

  • These are significant ingredients in the manufacturing of drugs and are also called bulk drugs.
  • The Hubei province of China is the hub of the API manufacturing industry.

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel –

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....

Sign Up To Receive Regular Updates